Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in rheumatoid arthritis (RA)

2024-9-30

Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort

2024-9-28

Patients’ recollection about the onset of Sjögren’s disease – a mixed methods study on the patients’ perspective

2024-9-28

Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort

2024-9-28

Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus

2024-9-28

Effects of chronic ankle instability after grade I ankle sprain on the post-traumatic osteoarthritis

2024-9-28

Small extracellular vesicles derived from synovial fibroblasts contain distinct miRNA profiles and contribute to chondrocyte damage in osteoarthritis

2024-9-28

Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis

2024-9-20

Increased predictive value of optical spectral transmission in early rheumatoid arthritis through use of patient-adjusted cut-off scores

2024-9-20

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

2024-9-18

A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review

2024-9-18

Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study

2024-9-18

Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients

2024-9-17

Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus

2024-9-14

Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy

2024-9-11

Activation of circulating TFH17 cells associated with activated naive and double negative 2 B cell expansion, and disease activity in systemic lupus erythematosus patients

2024-9-11

A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)

2024-9-7

Factors related to elevated serum immunoglobulin G4 (IgG4) levels in a Japanese general population

2024-9-6

A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases

2024-9-4

Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis

2024-8-31

Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib

2024-8-27

Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy

2024-8-22

Analysis of risk factors and development of a nomogram prediction model for renal tubular acidosis in primary Sjogren syndrome patients

2024-8-22

Inclusion of fibrinoid necrosis increases the accuracy of synovial tissue assessment in predicting response to methotrexate: analysis of the UCLouvain Brussels ERA Cohort

2024-8-19

Retraction Note: Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes

2024-8-7

The mode of action of IL-23 in experimental inflammatory arthritic pain and disease

2024-8-6

Significant overlap of inflammatory and degenerative features on imaging among patients with degenerative disc disease, diffuse idiopathic skeletal hyperostosis and axial spondyloarthritis: a real-life cohort study

2024-8-3

IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro

2024-7-30

Expression of CD163 and major histocompatibility complex class I as diagnostic markers for idiopathic inflammatory myopathies

2024-7-30

Infrapatellar fat pad size and subcutaneous fat in knee osteoarthritis radiographic progression: data from the osteoarthritis initiative

2024-7-30

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

2024-7-29

Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies

2024-7-29

Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry

2024-7-26

Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia

2024-7-26

Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging

2024-7-25

Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog

2024-7-25

Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study

2024-7-19

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

2024-7-18

Stabilizing the integrity of intestinal barrier to control arthritis

2024-7-18

JAK inhibitors attenuate hyperactivation of nonswitched memory B cells in rheumatoid arthritis patients in remission

2024-7-17

A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases

2024-7-16

Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis

2024-7-16

TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis

2024-7-15

The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection – a novel disease-modifying osteoarthritis drug

2024-7-12

Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study

2024-7-12

Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

2024-7-9

The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis

2024-7-8

Investigation of ferroptosis-associated molecular subtypes and immunological characteristics in lupus nephritis based on artificial neural network learning

2024-7-3

The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes

2024-6-25

S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis

2024-6-25